Cargando…
Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study)
In chronic kidney disease (CKD), the gut-microbiota metabolites indoxyl sulfate (IS) and p-cresyl sulfate (PCS) progressively accumulate due to their high albumin-binding capacity, leading to clinical complications. In a prospective crossover controlled trial, 60 patients with CKD grades 3B–4 (GFR =...
Autores principales: | Di Iorio, Biagio Raffaele, Rocchetti, Maria Teresa, De Angelis, Maria, Cosola, Carmela, Marzocco, Stefania, Di Micco, Lucia, di Bari, Ighli, Accetturo, Matteo, Vacca, Mirco, Gobbetti, Marco, Di Iorio, Mattia, Bellasi, Antonio, Gesualdo, Loreto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780815/ https://www.ncbi.nlm.nih.gov/pubmed/31510015 http://dx.doi.org/10.3390/jcm8091424 |
Ejemplares similares
-
Ketoanalogs’ Effects on Intestinal Microbiota Modulation and Uremic Toxins Serum Levels in Chronic Kidney Disease (Medika2 Study)
por: Rocchetti, Maria Teresa, et al.
Publicado: (2021) -
Improving the In Vitro Removal of Indoxyl Sulfate and p-Cresyl Sulfate by Coating Diatomaceous Earth (DE) and Poly-vinyl-pyrrolidone-co-styrene (PVP-co-S) with Polydopamine
por: Cicco, Stefania Roberta, et al.
Publicado: (2022) -
Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-cresol Sulfate in Hemodialysis Patients: Results from an In Vitro Study and an In Vivo Pilot Trial (xuanro4-Nature 3.2)
por: Rocchetti, Maria Teresa, et al.
Publicado: (2020) -
Beta-Glucans Supplementation Associates with Reduction in P-Cresyl Sulfate Levels and Improved Endothelial Vascular Reactivity in Healthy Individuals
por: Cosola, Carmela, et al.
Publicado: (2017) -
An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients
por: Cosola, Carmela, et al.
Publicado: (2021)